- Home
- EXP vs CAI Comparison
EXP vs CAI Comparison
Compare EXP & CAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EXP | CAI |
|---|---|---|
| Founded | 1963 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Building Materials | Medical Specialities |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.0B | 6.2B |
| IPO Year | 1994 | 2025 |
Fundamental Metrics
Financial Performance| Metric | EXP | CAI |
|---|---|---|
| Price | $169.38 | $30.42 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 11 | 14 |
| Target Price | ★ $195.50 | $31.62 |
| AVG Volume (30 Days) | 428.6K | ★ 4.5M |
| Earning Date | 10-29-2026 | 11-04-2026 |
| Dividend Yield | ★ 0.59% | N/A |
| EPS Growth | N/A | ★ 69.79 |
| EPS | ★ 3.29 | N/A |
| Revenue | $495,023,000.00 | ★ $812,033,000.00 |
| Revenue This Year | $0.74 | $26.78 |
| Revenue Next Year | $3.12 | $19.27 |
| P/E Ratio | $51.85 | ★ N/A |
| Revenue Growth | N/A | ★ 96.97 |
| 52 Week Low | $160.02 | $14.19 |
| 52 Week High | $245.53 | $33.13 |
Technical Indicators
Market Signals| Indicator | EXP | CAI |
|---|---|---|
| Relative Strength Index (RSI) | 40.62 | 56.01 |
| Support Level | N/A | $16.52 |
| Resistance Level | $218.97 | $32.73 |
| Average True Range (ATR) | 4.02 | 2.09 |
| MACD | 0.77 | -0.10 |
| Stochastic Oscillator | 54.33 | 66.44 |
Price Performance
Historical ComparisonAbout EXP Eagle Materials Inc
Eagle Materials Inc produces and sells construction products and building materials. Construction products include cement, slag, concrete, and aggregates and building materials include cement and gypsum wallboard, and are sold to the construction and building industries. The firm organizes itself into two sectors: Heavy Materials, which includes the Cement and Concrete and Aggregates segments, and Light Materials, which includes the Gypsum Wallboard and Recycled Paperboard segments.
About CAI Caris Life Sciences Inc.
Caris Life Sciences Inc is a patient-centric, next-generation AI TechBio company. It develop and commercialize solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale.